Component: (Network and Table)
Network
00100 - Statement - BALANCE SHEETS
(http://www.marinuspharma.com/role/StatementBalanceSheets)
Table(Implied)
Slicers (applies to each fact value in each table cell)
Reporting Entity [Axis]0001267813 (http://www.sec.gov/CIK)
BALANCE SHEETSPeriod [Axis]
2016-12-31
2015-12-31
BALANCE SHEETS
 
 
ASSETS
 
 
Current assets:
 
 
Cash and cash equivalents
26,178,000  
51,722,000  
Short-term investments
3,922,000  
4,474,000  
Prepaid expenses and other current assets
199,000  
1,571,000  
Total current assets
30,299,000  
 
57,767,000  
 
Property and equipment, net
1,148,000  
31,000  
Investments
 
1,488,000  
Other assets
 
362,000  
Total assets
31,447,000  
 
59,648,000  
 
LIABILITIES AND STOCKHOLDERS’ EQUITY
 
 
Current liabilities:
 
 
Current portion of notes payable
3,500,000  
2,128,000  
Accounts payable
2,809,000  
3,146,000  
Accrued expenses
1,775,000  
2,161,000  
Total current liabilities
8,084,000  
 
7,435,000  
 
Notes payable
1,743,000  
5,236,000  
Other long-term liabilities
141,000  
56,000  
Total liabilities
9,968,000  
 
12,727,000  
 
Commitments and contingencies (Note 8)
xsi:nil  
xsi:nil  
Stockholders' equity:
 
 
Preferred stock, $0.001 par value; 25,000,000 shares authorized, no shares issued and outstanding
xsi:nil  
xsi:nil  
Common stock, $0.001 par value; 100,000,000 shares authorized, 19,734,351 issued and 19,705,120 outstanding at December 31, 2016 and 19,420,086 issued and 19,390,855 outstanding at December 31, 2015
20,000  
19,000  
Additional paid-in capital
147,288,000  
144,088,000  
Treasury stock at cost, 29,231 shares at December 31, 2016 and 2015
xsi:nil  
xsi:nil  
Accumulated deficit
(125,829,000) 
(97,186,000) 
Total stockholders’ equity
21,479,000  
 
46,921,000  
 
Total liabilities and stockholders’ equity
31,447,000  
 
59,648,000